<DOC>
	<DOCNO>NCT00898378</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood tissue laboratory patient cancer , patient colorectal polyps patient without polyp may help doctor learn change occur DNA identify biomarkers related cancer . PURPOSE : This research study look biomarkers blood tissue sample patient colorectal cancer colorectal polyp patient without polyp ( healthy volunteer ) .</brief_summary>
	<brief_title>Study Biomarkers Blood &amp; Tissue Samples From Patients With Colorectal Cancer Polyps &amp; Patients Without Polyps</brief_title>
	<detailed_description>OBJECTIVES : Primary - Perform metabolomic , lipidomic , glycoproteomic , proteomic , genomic ( OMIC ) profile use blood tissue sample patient colorectal cancer ( CRC ) colorectal adenomatous polyp patient without polyp . - Create OMIC profile predict risk CRC base difference observe patient CRC , patient colorectal adenomatous polyp , patient without polyp . Secondary - Create OMIC profile predict response toxicity specific chemotherapy , biological therapy , radiotherapy CRC . - Utilize novel knowledge discovery tool ( BioMap ) base literature mining , future , utilize result OMIC analyse identify interactive molecular pathway underlie development progression CRC . OUTLINE : Patients locally advance metastatic colorectal cancer stratify accord treatment ( first-line chemotherapy fluorouracil [ 5-FU ] /oxaliplatin 5-FU/irinotecan vs second- third-line chemotherapy irinotecan v biological therapy bevacizumab vs biological therapy cetuximab v radiotherapy ) . Blood tissue sample collect periodically laboratory study . Samples analyze metabolomics nuclear magnetic resonance , gas chromatography , liquid chromatography , mass spectrometry ; lipidomics , proteomics , glycoproteomics liquid chromatography mass spectrometry ; genomics ( single nucleotide polymorphism biomarkers ) PCR . Vitamin D status also assess . Patients complete diet-history lifestyle questionnaire baseline year 2 year . Healthy volunteer complete questionnaire baseline . After completion study , patient follow every 3 month 2 year , every 6 month 3 year , annually thereafter . Healthy volunteer follow study completion .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Meets 1 follow criterion : Diagnosis one following : Stage I II colorectal cancer ( CRC ) * Planning undergo surgery Stage III CRC* Planning undergo surgery follow adjuvant chemotherapy without neoadjuvant chemoradiotherapy Stage IV CRC Planning undergo chemotherapy biologic therapy ( bevacizumab , cetuximab , panitumumab ) Colorectal adenomatous polyp Planning undergo colonoscopy Healthy volunteer Planning undergo colonoscopy NOTE : *Patients previously resect stage II III CRC eligible provide undergo blood sample collection prior start chemotherapy PATIENT CHARACTERISTICS : Not pregnant Able undergo 8hour overnight fast prior metabolomic test Able attend followup treatment visit 24 month collection blood sample No prior concurrent invasive cancer CRC ( patient CRC ) No prior invasive cancer firstdegree relative know history CRC ( healthy volunteer patient colorectal polyp ) PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>healthy , evidence disease</keyword>
	<keyword>stage I colon cancer</keyword>
	<keyword>stage II colon cancer</keyword>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage I rectal cancer</keyword>
	<keyword>stage II rectal cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>adenomatous polyp</keyword>
</DOC>